Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock (NQ:RAIN)

7.100 +0.270 (+3.95%)
Streaming Delayed Price Updated: 11:41 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,194
Open 6.310
Bid (Size) 7.000 (6)
Ask (Size) 7.150 (1)
Prev. Close 6.830
Today's Range 5.990 - 7.650
52wk Range 1.750 - 10.84
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Industrials Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
-2.7%
-2.7%
1 Month
+176.8%
+176.8%
3 Month
+150.9%
+150.9%
6 Month
-2.7%
-2.7%
1 Year
-2.7%
-2.7%

More News

Read More
12 Industrials Stocks Moving In Monday's Intraday Session
Via Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer
From Rain Enhancement Technologies Holdco, Inc.
Via Business Wire
Pathos AI Completes Acquisition of Rain Oncology
From Pathos AI, Inc.
Via Business Wire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Rain Oncology Inc. (NASDAQ:RAIN) Long Term Investor Notice: Investigation over Possible Wrongdoing
Via SBWire
Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
From The Law Offices of Frank R. Cruz
Via Business Wire
RAIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – RAIN
From The Rosen Law Firm PA
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock publicly traded?
Yes, Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock is publicly traded.
What exchange does Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock trade on?
Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock?
The ticker symbol for Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock is RAIN on the Nasdaq Stock Market
What is the current price of Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock?
The current price of Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock is 7.100
When was Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock last traded?
The last trade of Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock was at 05/19/25 11:41 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.